0 Comments
0 Shares
40 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Biotech Disruption: Exosome Therapeutics Unlocking Next-Gen HealingThe exosome surge is a masterclass in the limitations of static research. When a sector is poised to triple in value within a few years, the old model—commissioning a white paper, waiting for peer reviews, and synthesizing data over months—is more than just slow. It is a liability. The core failures are structural: Lagging Indicators: Traditional reports capture clinical...0 Comments 0 Shares 181 Views 0 Reviews
-
Biotech Expansion and mRNA Technologies Fuel Viral Vector Market GrowthViral Vector and Plasmid DNA Manufacturing Market Expands with Gene Therapy and Precision Medicine Innovation Viral Vector and Plasmid DNA Manufacturing Market Overview The global Viral Vector and Plasmid DNA Manufacturing Market is experiencing substantial growth driven by increasing demand for gene therapies, rapid advancements in cell and gene therapy technologies, and expanding...0 Comments 0 Shares 77 Views 0 Reviews
-
Biotech Innovations Propel Phycoerythrin Market Toward USD 11.30 Million by 2035NEWARK, Del., USA | April 28, 2026 — According to Future Market Insights (FMI), the global phycoerythrin market is projected to grow from USD 5.18 million in 2025 to approximately USD 11.30 million by 2035, registering a CAGR of 8.1% over the forecast period. Growth is being fueled by increasing demand for natural colorants, rising adoption in fluorescence-based diagnostics, and...0 Comments 0 Shares 122 Views 0 Reviews
-
CHST15 Antibody Market Outlook for Pharmaceutical and Biotech IndustriesThe global CHST15 antibody market is gaining significant momentum due to the increasing focus on cancer research, molecular diagnostics, and targeted therapeutic development. CHST15 antibodies are widely utilized in biomedical research to study carbohydrate sulfotransferase 15 expression and its role in tumor progression, fibrosis, and inflammatory diseases. Growing investments in biotechnology...0 Comments 0 Shares 146 Views 0 Reviews
-
Global C1Glt Antibody Market Forecast Driven by Biotech InnovationThe C1Glt Antibody Market is expanding steadily as biotechnology companies and research institutions increasingly adopt advanced antibody technologies for disease research and biomarker discovery. C1GLT antibodies play an important role in studying glycosylation pathways associated with cancer progression, immune disorders, and chronic diseases. Rising focus on precision medicine, increasing...0 Comments 0 Shares 66 Views 0 Reviews
-
Natural Killer Cell Therapeutics Market Strategic Insights for Biotech FirmsThe oncology landscape is shifting toward more sophisticated, "off-the-shelf" cellular interventions that leverage the body’s innate immune system. The Natural Killer (NK) Cell Therapeutics Market was valued at USD 504.09 million in 2024 and is projected to skyrocket to USD 9,839.77 million by 2032, growing at an extraordinary CAGR of 109.97% during the...0 Comments 0 Shares 143 Views 0 Reviews
-
Why Viral Vector Purification Is Critical for Biotech SuccessThe viral vector purification market has crossed a strategic threshold. The question is no longer whether demand for gene therapy and advanced vaccines will accelerate—it’s whether your organization has the intelligence infrastructure to act on that acceleration before competitors do. Market disruptions in bioprocessing have a history of accelerating structural shifts....0 Comments 0 Shares 229 Views 0 Reviews
-
Automated Liquid Handling Market to Reach USD 2.57 Billion by 2033, Growing at 7.98% CAGRMarket Overview The global automated liquid handling market size was valued at USD 1.29 billion in 2024 and is estimated to grow from USD 1.39 billion in 2025 to reach USD 2.57 billion by 2033, growing at a CAGR of 7.98% during the forecast period (2025–2033). The global Automated Liquid Handling market is...0 Comments 0 Shares 1K Views 0 Reviews
-
Global Diabetic Neuropathy Market to Reach USD 11.07 Billion by 2033, Exhibiting an 8.2% CAGRThe global diabetic neuropathy market size was valued at USD 5.45 billion in 2024 and is expected to grow from USD 5.89 billion in 2025 to USD 11.07 billion by 2033, growing at a CAGR of 8.2% during the forecast period (2025-2033). Market Overview The global Diabetic Neuropathy market is witnessing swift transformation driven by new consumer...0 Comments 0 Shares 1K Views 0 Reviews
-
Pharmaceutical Firms Increase Investments in Cell Therapy Monitoring KitsThe cell therapy monitoring kits market is experiencing significant growth as the healthcare industry increasingly embraces advanced cell-based therapies for the treatment of complex diseases. The global cell therapy monitoring kits market size was estimated at USD 1.4 billion in 2025 and is projected to reach USD 2.5 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. This growth is...0 Comments 0 Shares 83 Views 0 Reviews
-
Precision Drug Discovery 2026 Summit Boston | Register NowThe Ultimate Drug Discovery 2026 Summit Every Pharma Professional Must Attend The pharmaceutical and biotech world is changing at a speed we have never seen before. New technologies, artificial intelligence, and advanced research methods are rewriting how we find and develop new drugs. If you work in drug discovery, preclinical research, or life sciences, you need to stay ahead of these...0 Comments 0 Shares 570 Views 0 Reviews
-
Top Clinical Conferences Driving Modern Clinical ResearchWhy Are Top Clinical Conferences Important for Clinical Research Professionals? The clinical research industry continues to evolve rapidly as pharmaceutical companies, biotechnology firms, and research institutions seek innovative ways to develop safe and effective treatments. Attending top clinical conferences allows professionals to stay informed about industry advancements while connecting...0 Comments 0 Shares 409 Views 0 Reviews
-
Vaccine Adjuvants Market Bolstered by Focus on Enhanced Immunogenicity"Executive Summary Vaccine Adjuvants Market : CAGR Value The global Vaccine Adjuvants market was valued at USD 1.73 billion in 2024 and is expected to reach USD 4.74 billion by 2032 Trustworthy sources such as websites, journals, mergers, newspapers and other authentic sources have been referred to collect all the stats, data, facts and figures required to structure this Vaccine...0 Comments 0 Shares 2K Views 0 Reviews
More Results